Observational studyMedicine2018

Retrospective analysis of concurrent docetaxel and epirubicin neoadjuvant versus adjuvant chemotherapy: Which leads to better outcomes for different subtype breast cancer patients?

Houpu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.